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Synthesis of Triaminopyrimidine Derivatives for
Inhibition of Inflammatory Caspases
Marianna C. Haddad*
Department of Chemistry and Biochemistry

Caitlin E. Karver, PhD; Faculty Advisor
Department of Chemistry and Biochemistry

ABSTRACT Caspases are cysteine-dependent aspartic proteases whose functions are connected to
different mechanisms of cell death and inflammation. As caspase-1 plays a significant role in the
immune response, its activity has been of interest as a target for inhibitor development as its inhibition
will reduce the levels of pro-inflammatory cytokines in inflammatory diseases, thus minimizing the
symptoms that arise and serving as a possible therapeutic approach. Prior work discovered a family of
potent inhibitors of caspase-1 with a common triaminopyrimidine scaffold. To further explore structureactivity relationship profiles of potential inhibitors of caspase-1, two different syntheses were attempted
to create two new series of analogs for future activity studies. The syntheses presented here were
conducted to investigate whether the variation of the amino groups on the pyrimidine scaffold effect the
inhibition of caspase-1. The successful synthesis of the desired compounds has not yet been
accomplished, but the optimizations of the reactions for further studies are reported.
INTRODUCTION
Caspases-1, 4, and 5 are cysteine-dependent,
aspartate specific proteases that are involved in
the inflammatory response. The activation of
caspase-1 occurs upon the recognition of
pathogen- and damage-associated molecular
patterns (PAMPs and DAMPs, respectively) by
NOD-like receptors. This leads to the generation
of a multi-protein complex known as the
inflammasome.6 The biological substrates for
caspase-1 are the inactive forms of prointerleukin-1β and pro-interleukin-18, which are
cleaved by caspase-1 to form the active cytokines
IL-1β and IL-18.5 Overactivation of caspase-1
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has been linked to inflammatory cancers and
autoimmune disorders, including type II diabetes,
gout, and rheumatoid arthritis.5 The involvement
of caspases-1, 4, and 5 in the inflammatory and
innate immune responses has led to the interest of
designing and optimizing synthetic pathways that
may yield potential inhibitors of caspase activity.
Research on inflammatory caspases has led to the
discovery
of
a
family
of
potent
triaminopyrimidine
inhibitors.
The
triaminopyrimidine scaffold was discovered
through a library screening of potential scaffolds
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but caspase-1 is the enzyme of most interest as it
is the most characterized and understood of the
human inflammatory caspases in terms of its
functions and abilities.
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Figure 1. Structures of CK-1-41 and new analogs
1 and 2. CK-1-41 is the lead compound for
development of new analogs.

for such inhibitors. Within the library screen,
there
were
two
lazaroids
with
a
triaminopyrimidine heterocyclic scaffold that
exhibited the highest potency in the inhibition of
caspase-1.2 With this in mind, further work was
done to optimize the scaffold and aromatic linker
length, which led to the successful synthesis of
triaminopyrimidine derivatives that have also
been screened as effective inhibitors of caspases1, 4, and 5. The previously synthesized
derivative, CK-1-41, (Figure 1) has been
identified as the most potent inhibitor of caspases.
Using a fluorescence-based activity assay, CK-141 was determined to have an IC50 value of 56 ±
1 nM, which indicates that it is relatively potent
in terms of inhibiting caspase-1.3 The compound
is equally effective in inhibiting caspases-4 and 5,
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The potency of triaminopyrimidine derivatives
has shaped the focus of current research in the
Karver lab at DePaul University. Previously
discovered inhibitors of the inflammatory
caspases have been identified to bind in either the
active site of caspases or at an allosteric site.3
However, compound CK-1-41 and other
triaminopyrimidine analogs synthesized by the
Karver lab exhibited non-competitive inhibition,
thus inhibitor binding prevents catalysis without
altering affinity of the substrate for the active site.
The
exact
binding
location
of
the
triaminopyrimidines is unknown, and its
determination using activity-based probes and
proteomic analysis is a focus in other projects in
the Karver lab. The identity of the attached
substituent on the piperazine ring has the ability
to impact the mode of inhibition as well as the
selectivity between inflammatory caspases.3
Thus far, the ethylbenzene analog CK-1-41 has
demonstrated an increase in potency in the
inhibition of the inflammatory caspases. Efforts
are now focused on identifying and analyzing the
effects of varying the amino groups on the
pyrimidine scaffold. Initial structure-activity
relationship studies will commence upon
synthesis of ethylbenzene analogs of bisdimethylamino pyrimidine (1) and dimorpholino
(2) (Figure 1) for direct comparison to CK-1-41.
Further variations can be done on the aryl ring
using intermediates 4 and 6 (Scheme 1). To date,
there have been limited reports of incorporating a
piperazine ring onto a diaminopyrimidine core.
Previous literature provided conditions for the
synthesis
of
4-(1-piperazinyl)-2,6-di-1pyrrolidinylpyrimidine, which consists of
refluxing the starting material with piperazine in
pyridine.1 This served as a starting point for the
reaction trials presented here.

2

Haddad and Karver: Synthesis of Triaminopyrimidines as Inhibitors of Inflammatory Caspases

METHODS
General Methods
All chemical reagents utilized for the synthesis
reactions were obtained from Enamine. Thinlayer chromatography (TLC) utilized silica gel 60
F254 coated aluminum foil sheets. TLC analysis
was performed in 1:1 and 3:1 hexanes and ethyl
acetate, as well as 95:5% dichloromethane
(DCM) and methanol. All TLC solvent systems
contained 1% triethylamine (TEA). Microwave
reactions were conducted in a CEM Synthesizer
Discover
SP
reactor
system.
Gas
chromatography-mass spectrometry (GC-MS)
was performed with the use of Agilent
Technologies 7820A GC System and 5977E MS
Detector. To retrieve the nuclear magnetic
resonance 1H (NMR) data, a Bruker 400MHz
Neo Avance spectrometer was utilized. The
solvent used for NMR samples was CDCl3 and
the reference peak was set for tetramethylsilane
(TMS).
Benchtop Synthesis Reactions
All reactions completed on hot-plates and
aluminum blocks followed a similar procedure.
In either a 3-mL vial or 10-mL round-bottom
flask, 0.100 mmol of the starting core
(dimethylamino or dimorpholino core) was
combined with 1 mL of the chosen solvent (THF
or pyridine) and piperazine (equivalents of
piperazine used in each reaction is shown in
Table 1). A magnetic stir bar was added into the
vial or round-bottom flask, which was then
placed on a hot-plate for the time and temperature
specified in Table 1. The reactions were
monitored through TLC and GC-MS. Reactions
were ended when no further progress was
observed or if decomposition of the products was
evident.

Published by Via Sapientiae, 2022

Microwave-Assisted Synthesis
The preparation of these reactions consisted of
combining the starting material (dimorpholino or
dimethylamino core) with excess equivalents of
piperazine (Table 2) and 1 mL of the chosen
solvent (if any solvent was used) in a microwave
vial. The temperature and time of the reactions
vary and can be found in Table 2. The vial
containing the reagents was reacted in a
microwave reactor. The reactions were monitored
through TLC analysis to check the progress of
product formation.
General Reaction Workup
Any reactions that exhibited potential product
formation by TLC were subjected to an aqueous
workup. Extraction for reactions that used
tetrahydrofuran (THF) as the solvent proceeded
by diluting the product with ~5 mL of ethyl
acetate (EtOAc) followed by extraction with
water (3 x 5 mL). For reactions utilizing pyridine
as a solvent, the products were extracted with
deionized water and DCM (2 x 5 mL). The
aqueous phase was removed and the product was
washed with sodium bicarbonate. Extraction for
solvent-free reactions mirrored the extraction
method of when pyridine and THF were used. All
products were then dried with sodium sulfate
anhydrous (Na2SO4) and solvent was removed in
vacuo. Upon reaction completion, NMR samples
were created by placing small amounts of the
purified product into an NMR tube with CDCl3 as
the solvent.
RESULTS
Triaminopyrimidine derivatives of CK-1-41,
specifically derivatives with varying amine
substituents such as bis-dimethylamino and
dimorpholino groups (1 and 2, respectively,
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Scheme 1. Scheme for proposed syntheses of novel CK-1-41 analogs. The dimethylaminopyrimidine (3) and
dimorpholinopyrimidine (5) have been reacted with piperazine (7) via nucleophilic aromatic substitution. Compounds
4 and 6 will undergo an SN2 reaction with (2-bromoethyl)benzene to yield desired analogs 1 and 2.
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Figure 1) are novel compounds whose syntheses
have yet to be accomplished in our lab or in
others. They will be useful for providing
information on what alkyl groups are tolerated for
inhibition of caspase-1 at these positions, termed
structure-activity relationships (SAR). The
proposed general reaction schemes for the
synthesis of these compounds are shown in
Scheme 1. Once the piperazine is attached via
nucleophilic aromatic substitution (SNAr), the
addition of an ethyl linked-aryl substituent can
occur. These phenethyl analogs are mimics of the
potent CK-1-41 for a direct comparison of the
effects of the amino group changes on caspase-1
inhibition.
The conditions attempted for the synthesis of the
dimethylamino and dimorpholino variants via
benchtop synthesis are shown below in Table 1.
Four equivalents of piperazine (7) was
insufficient to drive the substitution reaction to
completion. The reaction was thus altered in
terms of the equivalents of piperazine used. The
equivalents of piperazine was increased to
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enhance the likelihood of the reaction going to
completion. The alteration of the solvent from
THF to pyridine did not improve the outcome as
monitored by TLC. All of these reactions were
unsuccessful as TLC analysis made it evident that
the starting material (3 or 5) was present to a large
extent in the samples. Although the reactions did
not reach completion, the TLC plates did depict
that some product may have been forming as
there was an unknown immobile spot on the
baseline of the TLC plate. Amines such as those
in compounds 4 and 6 are highly polar and
display very little mobility on a TLC. GC-MS
analysis indicated that the reaction did not yield
any identifiable product peaks. GC-MS was used
in place of NMR analysis for all benchtop
reactions due to the NMR being unavailable at the
time. GC-MS is not an ideal method of
characterization for the dimethylamino and
dimorpholino compounds as their size and
polarity make them difficult to ionize and
therefore identify in the spectra.
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Table 1. Reaction Conditions for the Benchtop Synthesis of Triaminopyrimidine Derivatives

Amount Equivalents Amount
Reaction
Corea of core
of 7
of 7
Identity
(mmol)
(mmol)

Temp
(℃)

Time
(days)

MH-1-32

0.114

3.6 eq.

0.411

THF

45

1

MH-1-34

0.127

3.3 eq.

0.419

THF

50

6

MH-1-36

0.100

3.0 eq.

0.302

THF

50

7

0.100

6.0 eq.

0.605

THF

50

2

MH-1-47

0.104

5.8 eq.

0.603

Pyridine

100

1

MH-1-48

0.104

5.8 eq.

0.603

Pyridine

100

6

MH-1-50

0.102

10 eq.

1.00

Pyridine

100

9

MH-1-33

0.100

3.9 eq.

0.389

THF

45

1

MH-1-35

0.100

3.8 eq.

0.376

THF

50

6

0.100

4.2 eq.

0.423

THF

45

7

0.100

6.3 eq.

0.625

THF

50

1

MH-1-49

0.198

3.5 eq.

0.700

Pyridine

100

6

MH-1-51

0.100

10 eq.

1.01

Pyridine

100

6

MH-1-38

MH-1-37
MH-1-39

a

Solvent

3

5

For all reactions, 1 equiv. of core was used.

The electron-donating (EDG) amine groups make
the attachment of a third nitrogen to the ring
particularly difficult. The presence of the EDG
groups makes the carbon atom undergoing
substitution (asterisk in Figure 2) less
electrophilic and thus less likely to react during
nucleophilic aromatic substitution reactions
(SNAr). Throughout the optimizations completed
thus far, it has been recognized that low
equivalents of piperazine have not been effective
enough to allow the reaction to go to completion.
Benchtop reaction conditions require extensive
amounts of reaction time and high temperatures.
During these reactions, product formation could
not be visualized on TLC plates in a timely
manner, thus other methods were attempted.
In order to improve the yields of product, a new
method, microwave-assisted synthesis, was
implemented. Microwave energy has been found
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to be more time efficient in driving chemical
reactions to completion.4 Microwave reactions
have also been shown to increase the percent
yield of products as well as enable greener
chemistry methods.4 Microwave reaction
conditions (Table 2) were initiated with smaller
equivalents of piperazine and the use of a solvent
(THF or pyridine). The use of a solvent in a
microwave reaction can be useful if it is known
to absorb microwave energy well. Solvents are
split into three separate categories when
analyzing their ability to absorb such energy:
high, medium, and low. The solvents used
throughout the syntheses in our work (THF and
pyridine) fall into the low absorbance category.6
This explains why the microwave conditions did
not improve the outcomes in THF or pyridine. As
the reactions progressed, it became evident that
the conditions needed to be further optimized.
Reactions were then carried out in excess
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Figure 2. Electron donating groups disrupt
nucleophilic aromatic substitution. The carbon
atom that becomes less electrophilic due to the
presence of the amine donating groups is depicted
with an asterisk.

piperazine without the use of a solvent. Running
reactions neat generally increases the rate of
collisions between reactants and simplifies
product isolation, especially in a microwave
reactor. The reagents have the capability of
absorbing the microwave energy, which allows
superheating of the mixture that is typically not

observed during conventional heating.4 The
analysis of the products formed through
microwave heating with TLC revealed that some
product formation occurred within a much more
favorable time range (minutes vs. days), which
indicates that microwave radiation and solventfree reactions provided a kinetic advantage. The
solvent-free reactions were done at a temperature
of 146 ℃, which is the boiling point of
piperazine. The specifics regarding equivalents,
temperature, solvent choice, and duration are
listed in Table 2.
The reactions that contained a solvent were
unsuccessful as TLC analysis depicted starting
material on the plate. This led to the recent
optimization of carrying out the reactions in the
absence of a solvent to allow more efficient
collisions to occur at a high enough temperature

Table 2. Reaction Conditions for Microwave-assisted Synthesis of Triaminopyrimidine Variant

Amount
core
(mmol)

Equivalents
of 7

Amount
of 7
(mmol)

Solvent
(1 mL)

Temp
(℃)

Time
(mins)

MH-1-54

0.104

2.9 eq.

0.308

THF

120

30

Crude
Yield
(%)
----

MH-1-56

0.104

10 eq.

1.01

THF

140

60

----

MH-1-62

0.108

10 eq.

1.02

THF

145

90

----

0.105

10 eq.

1.07

pyridine

165

90

----

MH-1-65

0.106

10 eq.

1.01

----

146

30

----

MH-1-66

0.106

10 eq.

1.03

----

146

60

----

MH-1-68

0.100

10 eq.

1.00

----

146

90

----

MH-1-55

0.105

6.7 eq.

0.707

pyridine

140

60

----

MH-1-57

0.100

10 eq.

0.100

THF

140

60

----

0.101

2.9 eq.

0.301

pyridineb

165

75

----

MH-1-69

0.100

10 eq.

1.03

----

146

65

86.2

MH-1-70

0.0997

10 eq.

1.09

----

146

90

>100

Reaction
Identity

MH-1-64

MH-1-61

a

Core

3

5

a

For all reactions, 1 equiv. of core was used. The volume of pyridine was increased to 4 mL.
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magnetic field due to the piperazine increasing
the overall electron density around the nucleus
resulting in a 1H signal that is shifted upfield to a
lower ppm.

N
Ha

N
N
3

N

Cl

Ha δ 5.28 ppm
N
Hb

N
N

N

N

4

NH

Hb δ 4.98 ppm

Figure
3.
Proton
of
interest
on
triaminopyrimidine
derivatives.
As
the
electronegative chlorine atom is displaced by the
substitution of the piperazine ring, the chemical shift
moves upfield since the electron density around the
nucleus slightly increases. Proton Ha is attached to
the starting core, while Hb is the proton that indicates
product formation.

(146 ℃). This optimization has shown that
product is indeed forming and is on the right path
of reaching completion. The reaction of MH-1-66
has shown the most progress thus far as its 1H
NMR spectrum (400MHz, CDCl3) depicted
peaks within the product region. As shown in
Figure 3, the chemical shift of 4.98 ppm indicates
product formation, while the peak at 5.28 ppm
corresponds to the presence of starting material.
The substitution of the chlorine atom by the
piperazine ring at position 6 of the
triaminopyrimidine core results in an upfield shift
of the ortho proton on the NMR spectrum due to
concept of electron density. The chlorine atom is
an electron withdrawing group and thus pulls
electron density away from the molecule, which
decreases the overall electron density
surrounding the nucleus. As the electron density
around the nucleus decreases, there is a larger
magnetic field felt by the nucleus and the signal
is shifted downfield to a higher ppm. The
attachment of the piperazine ring results in a
shielded nucleus that now experiences a smaller
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The 1H NMR spectrum that depicts the prominent
peaks from reaction MH-1-66 is shown in Figure
4. The reaction of MH-1-70 has also showed
progress as the TLC plate depicted the presence
of product as there is an immobile substance at
the baseline and similar Ha and Hb peaks on the
1
H NMR spectrum. The percent yield of MH-170 was above 100%, which indicates that the
sample is impure, most likely due to the presence
of water and piperazine. Future samples may be
subjected to high vacuum to thoroughly remove
any residual solvent that is still present after
rotary evaporation.
DISCUSSION
The microwave reactions have shown promise,
producing small amounts of product, with
starting material remaining. Future directions and
optimizations of these reactions will be
completed with the utilization of microwaveassisted synthesis, increasing the duration of the
reactions, and maintaining 10 equivalents of
piperazine in both the presence and absence of a
solvent. It is likely that the temperature will be
maintained at the boiling point of piperazine (146
℃) for neat reactions. The idea of refluxing the
reaction while in the microwave reactor may also
be attempted in the near future. The work-up and
analysis procedures will likely remain the same
unless minor modifications are necessary. With a
lack of research completed on the substitution of
a secondary amine on the aromatic
triaminopyrimidine core, the synthesis of these
compounds is considered novel. However, future
directions may also include researching possible
catalysts or reagents that have the potential of
favoring this nucleophilic substitution reaction to
aid in the process of driving the reaction to
completion. Once NMR analysis confirms the
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Figure 4. 1H NMR Spectrum of MH-1-66. Proton Ha indicates the presence of starting material in the sample at a
chemical shift of 5.28 ppm, while Hb depicts product formation at 4.98 ppm (refer to figure 4). The peaks ranging from
2.71-3.50 ppm refer to the methyl protons attached to the amine groups (N(CH3)2). Residual solvent peaks for CDCl3
(7.30 ppm) and water (1.50 ppm) are depicted in the spectrum as well.

presence of significant quantities of product, it
will be purified before proceeding with the
nucleophilic
substitution
reaction
with
bromoethylbenzene, specifically the conversion
of compound 4 to compound 1 and compound 6
to compound 2 (Scheme 1). The conditions for
attachment of the ethyl benzene portion of the
molecule are well established and should proceed
without difficulty as seen throughout the
synthesis of previous analogs within the Karver
lab.4 Once these compounds are synthesized and
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characterized, they will be screened for the
inhibitory ability with inflammatory caspases.
These compounds will provide future directions
for new reaction schemes and optimizations as
they will reveal patterns of the structure-activity
relationship profile for triaminopyrimidines with
these enzymes.
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